Pharma-Bio Serv, Inc. Quarterly Cost of Revenue in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2017 to Q2 2024.
  • Pharma-Bio Serv, Inc. Cost of Revenue for the quarter ending July 31, 2024 was $1.78M, a 41.1% decline year-over-year.
  • Pharma-Bio Serv, Inc. Cost of Revenue for the twelve months ending July 31, 2024 was $8.05M, a 36.9% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Cost of Revenue for 2023 was $11.9M, a 18% decline from 2022.
  • Pharma-Bio Serv, Inc. annual Cost of Revenue for 2022 was $14.5M, a 1.61% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Cost of Revenue for 2021 was $14.8M, a 0.96% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.05M $1.78M -$1.24M -41.1% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $9.3M $1.76M -$1.46M -45.3% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $10.8M $1.84M -$1.15M -38.5% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $11.9M $2.67M -$861K -24.4% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $12.8M $3.03M -$435K -12.6% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 $13.2M $3.22M -$535K -14.3% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $13.7M $3M -$776K -20.6% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $14.5M $3.53M -$569K -13.9% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 $15.1M $3.46M -$271K -7.26% May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q1 2022 $15.4M $3.75M +$618 +0.02% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $15.4M $3.77M +$601K +19% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 $14.8M $4.1M +$431K +11.8% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 $14.3M $3.73M -$691K -15.6% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $15M $3.75M -$28.1K -0.74% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $15M $3.17M +$146K +4.82% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $14.9M $3.67M +$382K +11.6% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 $14.5M $4.42M +$1.02M +30.1% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $13.5M $3.78M +$222K +6.24% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $13.3M $3.03M -$59.9K -1.94% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q3 2019 $13.3M $3.29M -$514K -13.5% Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 $13.8M $3.4M +$363K +12% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $13.5M $3.56M +$829K +30.4% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 $12.7M $3.09M +$542K +21.3% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $12.1M $3.8M Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 $3.04M -$14.6K -0.48% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 $2.73M -$152K -5.27% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 $2.55M Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q2 2017 $3.05M May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $2.88M Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.